Document:

Representation, Warranty and Indemnity Agreement

 Exhibit 10.17 

REPRESENTATION, WARRANTY AND INDEMNITY AGREEMENT 

THIS REPRESENTATION, WARRANTY AND INDEMNITY AGREEMENT (this “Agreement”) is made and entered into as of
February 15, 2010 (the “Effective Date”) by and among the parties listed on Exhibit A hereto (each individually a “Nominee,” and collectively, the “Nominees”), Hudson Pacific Properties,
L.P., a Maryland limited partnership (the “Operating Partnership”), and Hudson Pacific Properties, Inc., a Maryland corporation (the “Company”). Capitalized terms not expressly defined herein shall have the meanings
ascribed to such terms in the Contribution Agreement (defined below). 
 RECITALS 

WHEREAS, the Operating Partnership desires to consolidate the ownership of a portfolio of properties (the “Participating
Properties”) through a series of transactions (the “Formation Transactions”) whereby the Operating Partnership will acquire direct interests in the Participating Properties (the “Property Interests”) or,
directly or indirectly, some or all of the interests in certain limited partnerships, certain limited liability companies and certain other entities (collectively, the “Participating Partnerships”), which currently own or ground
lease, directly or indirectly, the Participating Properties, or a combination of the foregoing; 
 WHEREAS, the Formation
Transactions relate to the proposed initial public offering (the “Public Offering”) of the common stock (“Common Stock”) of the Company, which will operate as a self-administered and self-managed real estate
investment trust (“REIT”) within the meaning of Section 856 of the Internal Revenue Code of 1986, as amended (the “Code”) and which is the sole general partner of the Operating Partnership; 

WHEREAS, the owners of the Property Interests and the partners and members of the Participating Partnerships will either transfer their
Property Interests or interests in the Participating Partnerships, as applicable, to the Operating Partnership in exchange for cash, shares of Common Stock, common units of limited partnership interest (“OP Units”) in the Operating
Partnership and/or preferred units of limited partnership interest (“Series A Preferred OP Units”) in the Operating Partnership; 

WHEREAS, Glenborough Fund XIV, L.P., a Delaware limited partnership (the “Contributor”) and Glenborough Acquisition,
LLC, a Delaware limited liability company and general partner of the Contributor (“Glenborough GP”), have entered into a contribution agreement as of even date herewith (the “Contribution Agreement,” the form of
which is attached hereto as Exhibit B) to contribute to the Operating Partnership the Contributor’s interests in certain Participating Partnerships, including all of its rights, titles and interests, free and clear of all Liens, as
partner or member in each of the Partnerships, including, without limitation, all of its voting rights and interests in the capital, profits and losses of such Partnerships or any property distributable therefrom, constituting all of its interests
in and to such Partnerships (such right, title and interest in and to the Partnerships are hereinafter collectively referred to as the “Partnership Interests”), in exchange for cash, OP Units and/or Series A Preferred OP Units, as
applicable, on the terms and subject to the conditions set forth in the Contribution Agreement, to be delivered to the Contributor and the Nominees party hereto; 

WHEREAS, the parties acknowledge that the Operating Partnership’s (i) acquisition of the Partnership Interests, the Contributed
Assets and the Assumed Agreements (each as defined in Section 1.2 of the Contribution Agreement), and (ii) assumption of the Assumed Liabilities (as defined in Section 1.4 of the Contribution Agreement), is in anticipation of the
consummation of the Formation Transactions and the Public Offering. Additionally, it is understood that the Operating Partnership expects to acquire 

 
in the Formation Transactions the additional Participating Properties and Participating Partnerships indicated on Exhibit A-2 to the Contribution Agreement, and may acquire interests in
additional properties with the proceeds of the Public Offering. 
 WHEREAS, the parties further acknowledge that, in
connection with the Formation Transactions, each of the Nominees shall have certain rights and obligations with respect to the OP Units and/or Series A Preferred Units, as applicable, delivered to it pursuant to the Contribution Agreement,
including, but not limited to, the obligation to indemnify the Operating Partnership and the Company (each of which is an “Indemnified Party”) with respect to the breach of such Nominee’s representations, warranties and
covenants set forth in this Agreement, as and to the extent more particularly set forth herein. 
 NOW, THEREFORE, for
and in consideration of the foregoing premises, and the mutual undertakings set forth below, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

TERMS OF AGREEMENT 

ARTICLE I. 

REPRESENTATIONS AND WARRANTIES 

Each Nominee hereby severally, and not jointly or jointly and severally, represents and warrants to the Company and the Operating
Partnership as set forth below in this Article I, which representations and warranties are true and correct in all material respects (except for such representations and warranties that are qualified by materiality or Material Adverse Effect (as
defined below), which representations and warranties shall have been true and correct in all respects) as of the date hereof and will (except to the extent expressly relating to a specified date) be true and correct in the manner described above as
of the date of Pre-Closing: 
 Section 1.1 Organization; Authority; Qualification. Such Nominee that is not an
individual has been duly formed, and is validly existing and in good standing, to the extent applicable, under the laws of the jurisdiction of its formation. Such Nominee that is not an individual has all requisite power and authority to enter into
this Agreement, each agreement contemplated hereby to which it is a party and to carry out the transactions contemplated hereby and thereby. 

Section 1.2 Due Authorization; Capacity. The execution, delivery and performance of this Agreement by such Nominee that is
not an individual have been duly and validly authorized by all necessary action of such Nominee and its members or partners. Such Nominee that is an individual has the legal capacity to enter into this Agreement. This Agreement and each agreement,
document and instrument executed and delivered by or on behalf of such Nominee pursuant hereto constitutes, or when executed and delivered will constitute, the legal, valid and binding obligation of such Nominee, each enforceable against such
Nominee in accordance with its terms, as such enforceability may be limited by bankruptcy or the application of equitable principles. 

Section 1.3 Consents and Approvals. Except as shall have been satisfied prior to the Closing Date and as set forth in
Schedule 2.3 to the Disclosure Schedule to the Contribution Agreement, as of the date hereof, no consent, waiver, approval or authorization of any third party or Governmental Entity is required to be obtained by such Nominee in connection
with the execution, delivery and performance of this Agreement and the transactions contemplated hereby, except for those consents, waivers, approvals or authorizations, the failure of which to obtain would not have a material adverse effect on the
ability of such Nominee to consummate the transactions contemplated hereby (a “Material Adverse Effect”). 
  

 2 

 Section 1.4 No Violation. Except as shall have been cured to the reasonable
satisfaction of the Operating Partnership, consented to or waived in writing by the Operating Partnership prior to the Closing Date or as set forth in Schedule 2.5 to the Disclosure Schedule to the Contribution Agreement, none of such
Nominee’s execution, delivery or performance of this Agreement, any agreement contemplated hereby and the transactions contemplated hereby and thereby does or will, with or without the giving of notice, lapse of time, or both, violate, conflict
with, result in a breach of, or constitute a default under or give to others any right of termination, acceleration, cancellation or other right adverse to the Operating Partnership of (A) the organizational documents, including the operating
agreement, if any, of such Nominee that is not an individual, (B) any agreement, document or instrument to which such Nominee is a party or by which such Nominee is bound or (C) any term or provision of any judgment, order, writ,
injunction, or decree, or require any approval, consent or waiver of, or make any filing with, any person or governmental or regulatory authority or foreign, federal, state, local or other law binding on such Nominee or any of its assets or
properties; provided, in the case of (B) and (C) above, unless any such violation, conflict, breach, default or right would not have a Material Adverse Effect. 

Section 1.5 Non-Foreign Status. Such Nominee is a United States person (as defined in Section 7701(a)(30) of the Code),
and is, therefore, not subject to the provisions of the Code relating to the withholding of sales proceeds to foreign persons, and is not subject to any state withholding requirements. Such Nominee will provide affidavits at the Closing to this
effect as provided for in Section 4.1(c) of this Agreement. 
 Section 1.6 Withholding. Such Nominee shall
execute at Closing such certificates or affidavits reasonably necessary to document the inapplicability to it of any United States federal or state withholding provisions, including without limitation those referred to in Section 1.5 above. If
such Nominee fails to provide such certificates or affidavits, the Operating Partnership may withhold a portion of any payments otherwise to be made to such Nominee as required by the Code or applicable state law. To the extent amounts are so
withheld by the Operating Partnership, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the applicable Nominee. 

Section 1.7 Investment Purposes. Such Nominee acknowledges its understanding that the offering and issuance of the OP Units
and/or Series A Preferred OP Units to be acquired by it pursuant to the Contribution Agreement, as a nominee of the Contributor thereunder, are intended to be exempt from registration under the Securities Act of 1933, as amended, and the rules and
regulations in effect thereunder (the “Act”) and that the Operating Partnership’s reliance on such exemption is predicated in part on the accuracy and completeness of the representations and warranties of such Nominee contained
herein. In furtherance thereof, such Nominee, severally, and not jointly or jointly and severally, represents and warrants to the Company and the Operating Partnership as follows: 

1.7.1 Investment. Such Nominee is acquiring OP Units and/or Series A Preferred OP Units solely for its own account
for the purpose of investment and not as a nominee or agent for any other person (other than the Contributor) and not with a view to, or for offer or sale in connection with, any distribution of any thereof. Such Nominee agrees and acknowledges that
it will not, directly or indirectly, offer, transfer, sell, assign, pledge, hypothecate or otherwise dispose of (hereinafter, “Transfer”) any of the OP Units or Series A Preferred OP Units, as applicable, unless (i) the
Transfer is pursuant to an effective registration statement under the Act and qualification or other compliance under applicable blue sky or state securities laws, (ii) counsel for the Contributor (which counsel shall be reasonably acceptable
to the Operating Partnership, it being agreed that Goodwin Procter LLP is acceptable to the Operating Partnership) shall have furnished the Operating Partnership with an opinion, reasonably satisfactory in form and substance to the Operating
Partnership, to the effect that no such registration is required because of the availability of an exemption from registration under the Act or (iii) the Transfer is 

 

 3 

 
otherwise permitted by the OP Agreement. The term “Transfer” shall not include any redemption of the OP Units or exchange of the OP Units for REIT Shares pursuant to Section 8.6 of
the OP Agreement. Notwithstanding the foregoing, no Transfer shall be made unless it is permitted under the OP Agreement. 

1.7.2 Knowledge. Such Nominee is knowledgeable, sophisticated and experienced in business and financial matters and
fully understands the limitations on transfer imposed by the Federal securities laws and as described in this Agreement. Such Nominee is able to bear the economic risk of holding the OP Units and/or Series A Preferred OP Units for an indefinite
period and is able to afford the complete loss of its investment in the OP Units and/or Series A Preferred OP Units, as applicable; such Nominee has received and reviewed all information and documents about or pertaining to the Company, the
Operating Partnership, the business and prospects of the Company and the Operating Partnership and the issuance of the OP Units and/or Series A Preferred OP Units, as applicable, as such Nominee deems necessary or desirable, has had cash flow and
operations data for the Properties made available by the Operating Partnership upon request and has been given the opportunity to obtain any additional information or documents and to ask questions and receive answers about such information and
documents, the Company, the Operating Partnership, the Properties, the business and prospects of the Company and the Operating Partnership and the OP Units and/or Series A Preferred OP Units, as applicable, which such Nominee deems necessary or
desirable to evaluate the merits and risks related to its investment in the OP Units and/or Series A Preferred OP Units, as applicable, and to conduct its own independent valuation of the Properties. Such Nominee has reviewed with its legal counsel
and tax advisors the forms of Articles of Amendment and Restatement, Amended and Restated Bylaws and OP Agreement (forms of which are attached as Appendix B, Appendix C and Appendix D to the Contribution Agreement,
respectively). 
 1.7.3 Holding Period. Such Nominee acknowledges that it has been advised that
(i) the OP Units and Series A Preferred OP Units are not redeemable or exchangeable for REIT Shares for a minimum of fourteen (14) months and three (3) years, respectively, (ii) the OP Units and Series A Preferred OP Units issued
pursuant to the Contribution Agreement, and any REIT Shares issued in exchange for, or in respect of a redemption of, OP Units and/or Series A Preferred OP Units, as applicable, are “restricted securities” (unless registered in accordance
with applicable U.S. securities laws) under applicable federal securities laws and may be disposed of only pursuant to an effective registration statement or an exemption therefrom and such Nominee understands that the Operating Partnership has no
obligation or intention to register any OP Units and/or Series A Preferred OP Units, except to the extent set forth in the Registration Rights Agreement; accordingly, such Nominee may have to bear indefinitely, the economic risks of an investment in
such OP Units and/or Series A Preferred OP Units, (iii) a restrictive legend in the form hereafter set forth shall be placed on the OP Unit Certificates and the Series A Preferred OP Unit Certificates (and any certificates representing REIT
Shares for which OP Units and/or Series A Preferred OP Units may, in certain circumstances, be exchanged or redeemed), and (iv) a notation shall be made in the appropriate records of the Operating Partnership and the Company indicating that the
OP Units and Series A Preferred OP Units (and any REIT Shares for which OP Units and/or Series A Preferred OP Units may, in certain circumstances, be exchanged or redeemed) are subject to restrictions on transfer. 

1.7.4 Accredited Investor. Such Nominee is an “accredited investor” (as such term is defined in Rule
501(a) of Regulation D under the Act). Such Nominee has previously provided the Operating Partnership and the Company with a duly executed Accredited Investor Questionnaire. No event or circumstance has occurred since delivery of such Nominee’s
Questionnaire to make the statements contained therein false or misleading. 
  

 4 

 1.7.5 Legend. Such Nominee acknowledges that each OP Unit Certificate
and Series A Preferred OP Unit Certificate, if any, issued pursuant to the Contribution Agreement (and any certificates representing REIT Shares for which OP Units and/or Series A Preferred OP Units may, in certain circumstances, be exchanged or
redeemed), unless registered in accordance with applicable U.S. securities laws, shall bear the following legend: 
 The
securities evidenced hereby have not been registered under the Securities Act of 1933, as amended (the “Act”), or the securities laws of any state and may not be sold, transferred or otherwise disposed of in the absence of such
registration, unless, except in limited circumstances, the transferor delivers to the company an opinion of counsel satisfactory to the company, to the effect that the proposed sale, transfer or other disposition may be effected without registration
under the Act and under applicable state securities or “Blue Sky” laws; 
 Such Nominee acknowledges
that, in addition to the foregoing legend, each certificate (if any) representing any REIT Shares for which the OP Units and/or Series A Preferred OP Units may, in certain circumstances, be exchanged or redeemed shall also bear a legend which
generally provides the following: 
 The shares represented by this certificate are subject to restrictions on Beneficial and
Constructive Ownership and Transfer for the purpose, among others, of the Corporation’s maintenance of its status as a Real Estate Investment Trust under the Internal Revenue Code of 1986, as amended (the “Code”). Subject to
certain further restrictions and except as expressly provided in the Corporation’s Charter, (i) no Person may Beneficially or Constructively Own shares of the Corporation’s Common Stock in excess of 9.8% (in value or number of shares)
of the outstanding shares of Common Stock of the Corporation unless such Person is an Excepted Holder (in which case the Excepted Holder Limit shall be applicable); (ii) no Person may Beneficially or Constructively Own shares of Capital Stock
of the Corporation in excess of 9.8% of the value of the total outstanding shares of Capital Stock of the Corporation, unless such Person is an Excepted Holder (in which case the Excepted Holder Limit shall be applicable); (iii) no Person may
Beneficially or Constructively Own Capital Stock that would result in the Corporation being “closely held” under Section 856(h) of the Code or otherwise cause the Corporation to fail to qualify as a REIT; and (iv) no Person may
Transfer shares of Capital Stock if such Transfer would result in the Capital Stock of the Corporation being owned by fewer than 100 Persons. Any Person who Beneficially or Constructively Owns or attempts to Beneficially or Constructively Own shares
of Capital Stock which causes or will cause a Person to Beneficially or Constructively Own shares of Capital Stock in excess or in violation of the above limitations must immediately notify the Corporation. If any of the restrictions on transfer or
ownership set forth in (i) through (iii) above are violated, the shares of Capital Stock represented hereby will be automatically transferred to a Trustee of a Trust for the benefit of one or more Charitable Beneficiaries. In addition, the
Corporation may take other actions, including redeeming shares upon the terms and conditions specified by the Board of Directors in its sole and absolute discretion if the Board of Directors determines that ownership or a Transfer or other event may
violate the restrictions described above. Furthermore, upon the occurrence of certain events, attempted Transfers in violation of the restrictions described above may be void ab initio. All capitalized terms in this legend have the meanings
defined in the Charter of the Corporation, as the same may be amended from time to time, a copy of which, including the restrictions on transfer and ownership, will be furnished to each holder of Capital Stock of the Corporation on request and
without charge. Requests for such a copy may be directed to the Secretary of the Corporation at its Principal Office. 
  

 5 

 Section 1.8 No Brokers. Except as set forth in Schedule 2.9 to the
Disclosure Schedule to the Contribution Agreement, neither such Nominee nor any of its officers, directors or employees, to the extent applicable, has employed or made any agreement with any broker, finder or similar agent or any person or firm
which will result in the obligation of the Company, the Operating Partnership or any of their affiliates (including any of the Partnerships and/or Entities) to pay any finder’s fee, brokerage fees or commissions or similar payment in connection
with the transactions contemplated by the Contribution Agreement. 
 Section 1.9 Exclusive Representations. Except
as set forth herein, such Nominee makes no representation or warranty of any kind, express or implied, and each of the Operating Partnership and the Company acknowledges that it has not relied upon any other such representation or warranty.

 ARTICLE II. 

RESERVED 
 ARTICLE
III. 
 INDEMNIFICATION 

Section 3.1 Survival Of Representations And Warranties; Remedy For Breach. 

(a) Subject to Section 3.7 of this Agreement, all representations and warranties contained herein (as qualified by the Disclosure
Schedule to the Contribution Agreement) or in any Exhibit, certificate or affidavit delivered by a Nominee pursuant hereto shall survive the Closing. 

(b) Notwithstanding anything to the contrary in the Contribution Agreement or this Agreement, following the Closing and issuance of OP
Units and/or Series A Preferred OP Units to the applicable Nominees, no Nominee shall be liable under this Agreement for monetary damages (or otherwise) for breach of any of its representations, warranties, covenants and obligations contained in
this Agreement, or in any Exhibit, certificate or affidavit delivered by such Nominee pursuant hereto, other than pursuant to the succeeding provisions of this Article 3, which, except as provided in Sections 6.13, 6.14 and 6.15 of this
Agreement, shall be the sole and exclusive remedy with respect thereto. In furtherance of the foregoing provision relating to exclusive remedy, each of the Operating Partnership and the Company hereby expressly waives any rights or claims it may
have to pursue any remedy against the Nominees or any of their affiliates following the Closing and issuance of OP Units and/or Series A Preferred OP Units to the Nominees, whether under statute or common law, other than as provided in this Article
3 or in Sections 6.13, 6.14 and 6.15 of this Agreement. In no event shall the constituent members, partners, employees, officers, directors, managers, advisers, agents or representatives of any Nominee be liable for monetary damages (or otherwise)
for any breach of any of the representations, warranties, covenants and obligations contained in this Agreement or in any Exhibit, certificate or affidavit delivered by a Nominee pursuant hereto. 

Section 3.2 General Indemnification. 

(a) From and after the Closing Date, each Nominee shall, severally and not jointly or jointly and severally, indemnify, hold harmless and
defend each Indemnified Party from and against any and all “Losses” (i.e., claims, losses, damages, liabilities and expenses, including, without limitation, amounts paid in settlement, reasonable attorneys’ fees, costs of
investigation, costs of investigative, judicial or administrative proceedings or appeals therefrom, and costs of attachment or similar bonds) asserted against, imposed upon or incurred by the Indemnified Party, to the extent resulting from any

  

 6 

 
breach of a representation, warranty, covenant or obligation of such Nominee contained in this Agreement, or in any Exhibit, certificate or affidavit delivered by such Nominee pursuant hereto. In
each case, the Nominee shall (collectively, if applicable) only bear the fees, costs or expenses in connection with the employment of one counsel (regardless of the number of Indemnified Parties). 

(b) Each Nominee shall also, severally and not jointly or jointly and severally, indemnify and hold harmless the Indemnified Parties from
and against any and all Losses asserted against, imposed upon or incurred by the Indemnified Parties to the extent resulting from an unrelated third-party claim arising from such Nominee’s failure to timely pay any fees and expenses of such
Nominee for which it is responsible pursuant to this Agreement in connection with the transactions contemplated by this Agreement and the Contribution Agreement. 

(c) With respect to any claim of an Indemnified Party pursuant to this Section 3.2, to the extent available, the Operating
Partnership agrees to use diligent good faith efforts to pursue and collect any and all available proceeds and benefits of any right to defense under any insurance policy which covers the matter which is the subject of the indemnification prior to
seeking indemnification from a Nominee until all proceeds and benefits, if any, to which the Operating Partnership or the Indemnified Party is entitled pursuant to such insurance policy have been exhausted; provided, however, that the
Operating Partnership may make a claim under this Section 3.2 even if an insurance coverage dispute is pending, in which case, if the Indemnified Party later receives insurance proceeds with respect to any Losses paid by a Nominee for the
benefit of any Indemnified Party, then the Indemnified Party shall reimburse such Nominee in an amount equivalent to such proceeds in excess of any deductible amount pursuant to Section 3.6(a) up to the amount actually paid (or deemed paid) by
such Nominee to the Indemnified Party in connection with such indemnification (it being understood that all costs and expenses incurred by a Nominee with respect to insurance coverage disputes shall constitute Losses paid by such Nominee for
purposes of Section 3.2(a)). 
 3.3 Reserved. 

3.4 Reserved. 

3.5 Notice and Defense of Claims. As soon as reasonably practicable after receipt by the Indemnified Party of notice of any
liability or claim incurred by or asserted against the Indemnified Party that is subject to indemnification under this Article 3, the Indemnified Party shall give notice thereof to the applicable Nominee, including liabilities or claims to be
applied against the indemnification deductible established pursuant to Section 3.6 hereof; provided, that failure to give notice to such Nominee will not relieve such Nominee from any liability which it may have to any Indemnified Party,
unless, and only to the extent that, such failure (a) shall have caused prejudice to the defense of such claim or (b) shall have materially increased the costs or potential liability of such Nominee by reason of the inability or failure of
such Nominee (due to such lack of prompt notice) to be involved in any investigations or negotiations regarding any such claim. Such notice shall describe in reasonable detail the facts known to such Indemnified Party giving rise to such claim, and
the amount or good faith estimate of the amount of Losses arising therefrom. Unless prohibited by law, such Indemnified Party shall deliver to such Nominee, promptly after such Indemnified Party’s receipt thereof, copies of all notices and
documents received by such Indemnified Party relating to such claim. The Indemnified Party shall permit such Nominee, at the option and expense of such Nominee, to assume the defense of any such claim by counsel selected by such Nominee and
reasonably satisfactory to the Indemnified Party, and to settle or otherwise dispose of the same; provided, however, that the Indemnified Party may at all times participate in such defense at its sole expense; and provided further,
however, that no Nominee shall, in defense of any such claim, except with the prior written consent of the Indemnified Party in its sole and absolute discretion, consent to the entry of any judgment or enter into any settlement that does

  

 7 

 
not include as an unconditional term thereof the giving by the claimant or plaintiff in question to all Indemnified Parties a release of all liabilities in respect of such claims, or that does
not result only in the payment of money damages which are paid (or deemed paid) in full by the applicable Nominee. If the applicable Nominee shall fail to undertake such defense within 30 days after such notice, or within such shorter time as may be
reasonable under the circumstances to the extent required by applicable law, then the Indemnified Party shall have the right to undertake the defense, compromise or settlement of such liability or claim on behalf of and for the account of the
applicable Nominee at such Nominee’s sole cost and expense (subject to the limitations in Section 3.6); provided, however, that such Nominee will not be obligated to indemnify the Indemnified Parties for any compromise or settlement
entered into without such Nominee’s prior written consent, which consent shall not be unreasonably withheld or delayed. 

3.6 Limitations on Indemnification Under Section 3.2(a). 

(a) No Nominee shall be liable under Section 3.2(a) hereof unless and until the total amount recoverable by the Indemnified Parties
from such Nominee under Section 3.2(a) hereof exceeds one percent (1%) of the value of the aggregate Total Consideration (valuing OP Units based upon the initial public offering price of the Common Stock and valuing Series A Preferred OP
Units at Twenty-Five Dollars ($25.00) per unit), and then only to the extent of such excess. 
 (b) Notwithstanding anything
contained herein to the contrary, the maximum aggregate liability of a Nominee under Section 3.2(a) hereof shall not exceed ten percent (10%) of the value of such Nominee’s Total Consideration (valuing OP Units based upon the initial
public offering price of the Common Stock and valuing Series A Preferred OP Units at Twenty-Five Dollars ($25.00) per unit). Notwithstanding anything contained herein to the contrary, before taking recourse against any assets of the Nominees and
subject to the limitations set forth in the following sentence, the Indemnified Parties shall look first to available insurance proceeds (including without limitation any title insurance proceeds, if applicable) pursuant to Section 3.2(c)
above, for indemnification under this Article 3. Notwithstanding anything to the contrary in this Agreement, the Nominees shall not be liable to the Indemnified Parties for any indirect, special or consequential damages, loss of profits, Taxes
relating to Tax years beginning on or after the closing of the Formation Transactions, loss of value or other similar speculative damages asserted or claimed by the Indemnified Parties. 

3.7 Limitation Period. 

(a) Notwithstanding the foregoing, any claim for indemnification under Section 3.2 hereof must be asserted in
writing by the Indemnified Party, stating the nature of the Losses and the basis for indemnification therefor on or prior to the first
(1st) anniversary of the Closing. 

(b) Subject to Section 3.7(a), if asserted in writing on or prior to first
(1st) anniversary of the Closing, any claims for
indemnification pursuant to Section 3.2 shall survive until resolved by mutual agreement between the applicable Nominee and the Indemnified Party or pursuant to Section 6.14 of this Agreement, and any claim for indemnification pursuant to
Section 3.2 not so asserted in writing on or prior to the first
(1st) anniversary of the Closing shall not thereafter
be asserted and shall forever be waived. 
 ARTICLE IV. 

PRE-CLOSING; CLOSING 

Section 4.1 Pre-Closing Deliveries. On or before the Pre-Closing Date, the parties shall make, execute, acknowledge and
deliver into escrow with the Escrow Agent, or cause to be made, executed, acknowledged and delivered into escrow with Escrow Agent through the Attorney-in-Fact (as 

 

 8 

 
defined in Section 4.3 below), the legal documents and other items (collectively the “Closing Documents”) to which it is a party or for which it is otherwise responsible
that are necessary to carry out the intention of this Agreement and the Contribution Agreement and the other transactions contemplated to take place in connection therewith. The Closing Documents and other items to be delivered into escrow at the
Pre-Closing shall include, without limitation, the following: 
 (a) The OP Agreement; 

(b) The Amendment, OP Unit Certificates, Series A Preferred OP Unit Certificates and/or other evidence of the transfer of OP Units
and/or Series A Preferred OP Units to the Nominees; 
 (c) An affidavit from each Nominee stating, under penalty of
perjury, such Nominee’s United States Taxpayer Identification Number and that such Nominee is not a foreign person pursuant to Section 1445(b)(2) of the Code and a comparable affidavit satisfying California and any other withholding
requirements; 
 (d) A Tax Protection Agreement substantially in the form attached hereto as Exhibit J to the
Contribution Agreement with respect to each Nominee; 
 (e) A Debt Guarantee Agreement substantially in the form attached
to the Tax Protection Agreement as Annex D-1 or Annex D-2, as applicable, with respect to each applicable Nominee; and 

(f) The Operating Partnership and the Company, on the one hand, and each Nominee, on the other hand, shall provide to the other a
certified copy of all appropriate corporate resolutions or partnership or limited liability company actions (if applicable) authorizing the execution, delivery and performance by the Operating Partnership and the Company (if so requested by a
Nominee) and each Nominee (if so requested by the Operating Partnership or the Company) of this Agreement, and any related documents and the documents listed in this Section 4.1. 

Section 4.2 Closing; IPO Closing Deliveries. On or before the date of the IPO Closing, (i) the Closing Documents shall
be released from escrow and delivered to the applicable parties, and the Closing shall be deemed to have occurred, and (ii) the parties shall make, execute, acknowledge and deliver, or cause to be made, executed, acknowledged and delivered
through the Attorney-in-Fact, the legal documents and other items (collectively the “IPO Closing Documents”) to which it is a party or for which it is otherwise responsible that are necessary to carry out the intention of this
Agreement and the Contribution Agreement and the other transactions contemplated to take place in connection therewith, which IPO Closing Documents and other items shall include, without limitation, the following: 

(a) The Registration Rights Agreement, signed by or on behalf of the Contributor and each Nominee, certain other parties and the
Company, substantially in the form attached as Exhibit F to the Contribution Agreement; 
 (b) Lock-up
Agreements, signed by or on behalf of the Contributor and each Nominee, each such Lock-up to be substantially in the form attached as Exhibit G to the Contribution Agreement, and which shall have been executed and delivered concurrently with
the execution and delivery of this Agreement; 
 (c) If requested by the Operating Partnership, a certified copy of all
appropriate corporate resolutions or partnership actions (if applicable) authorizing the execution, delivery and performance by each Nominee of the documents listed in this Section 4.2. 

 

 9 

 Section 4.3 Grant of Power of Attorney. Each Nominee hereby irrevocably appoints
the Operating Partnership (or its designee) and any successor thereof from time to time (such Operating Partnership or designee or any such successor of any of them acting in his, her or its capacity as attorney-in-fact pursuant hereto, the
“Attorney-In-Fact”) as the true and lawful attorney-in-fact and agent of each such Nominee, to act in the name, place and stead of each of such Nominee to make, execute, acknowledge and deliver all such other deeds (including grant
deeds if applicable), assignments, contracts, orders, receipts, notices, requests, instructions, certificates, consents, letters and other writings (including without limitation the execution of any Closing Documents including, but not limited to,
any registration rights agreements, partnership agreements, pledge agreements and any lock-up agreements), to provide information to the Securities and Exchange Commission and others about the transactions contemplated hereby and, in general, to do
all things and to take all actions which the Attorney-in-Fact in its sole discretion may consider necessary or proper in connection with or to carry out the transactions contemplated by this Agreement, as fully as could the applicable Nominee if
personally present and acting (the “Power of Attorney”), provided, that the Operating Partnership may not take any such action on behalf of such Nominee unless such action is in accordance with the terms of this Agreement
and/or the Contribution Agreement and the Attorney-in-Fact has given such Nominee reasonable prior written notice (including by electronic means) to the address set forth on the signature page hereto for each action to be so taken by the
Attorney-in-Fact; and, provided further, the parties agree and acknowledge, for the benefit of each Nominee, that, notwithstanding any provision of this Section 4.3, the Attorney-In-Fact is not hereby or thereby granted, and shall not
purport to exercise, any authority to execute any instrument creating, directly or indirectly, any liability personal to any Nominee. 

The Power of Attorney and all authority granted hereby shall be coupled with an interest and therefore shall be irrevocable and shall not
be terminated by any act of the Nominees, and if any other such act or events shall occur before the completion of the transactions contemplated by this Agreement, the Attorney-in-Fact shall nevertheless be authorized and directed to complete all
such transactions as if such other act or events had not occurred and regardless of notice thereof. Each of the Nominees agrees that, at the request of Operating Partnership, it will promptly execute and deliver to the Operating Partnership a
separate power of attorney on the same terms set forth in this Section 4.3, such execution to be witnessed and notarized, and in recordable form (if necessary). Each Nominee hereby authorizes the reliance of third parties on the Power of
Attorney with respect to such Nominee. 
 The Nominees acknowledge that the Operating Partnership has, and any designee or
successor thereof acting as Attorney-in-Fact may have, an economic interest in the transactions contemplated by this Agreement. 

Section 4.4 Limitation on Liability. It is understood that the Attorney-in-Fact assumes no responsibility or liability to
any person by virtue of the Power of Attorney granted by each of the Nominees hereby. The Attorney-in-Fact makes no representations with respect to and shall have no responsibility in its capacity as Attorney-in-Fact for the Formation Transactions
or the Public Offering, or the acquisition of the Partnership Interests, the Contributed Assets or the Assumed Agreements by the Operating Partnership or the assumption of the Assumed Liabilities by the Operating Partnership and shall not be liable
in its capacity as Attorney-in-Fact for any error or judgment or for any act done or omitted or for any mistake of fact or law except for its own gross negligence or bad faith, or breach of this Agreement or the terms of its power of attorney
provided for herein. Each Nominee agrees to indemnify the Attorney-in-Fact for and to hold the Attorney-in-Fact harmless against any loss, claim, damage or liability (including reasonably attorneys’ fees) incurred on its part arising out of or
in connection with it acting as the Attorney-in-Fact under the Power of Attorney created by such Nominee hereby, as well as the cost and expense of investigating and defending against any such loss, claim, damage or liability, except to the extent
such loss, claim, damage or liability is due to its own gross negligence or bad faith, or breach of this Agreement or the terms of its power of attorney provided for herein. Each Nominee agrees

  

 10 

 
that the Attorney-in-Fact may consult with counsel of its own choice (who may be counsel for Operating Partnership or its successors or affiliates), at its own cost, and it shall have full and
complete authorization and protection for any action taken or suffered by it hereunder in good faith and in accordance with the opinion of such counsel. It is understood that the Attorney-in-Fact may, without breaching any express or implied
obligation to any Nominee hereunder, release, amend or modify any other power of attorney granted by any other person under any related agreement. 

Section 4.5 Ratification; Third Party Reliance. Each Nominee hereby ratifies and confirms that the Attorney-in-Fact shall lawfully
do or cause to be done by virtue of the exercise of the powers granted unto it by such Nominee under Section 4.3, and each Nominee authorizes the reliance of third parties on this Power of Attorney and waives its rights, if any, as against any
such third party for its reliance hereon. 
 ARTICLE V. 

WAIVERS AND CONSENTS 

Each of the releases and waivers enumerated in this Article 5 shall become effective only upon the Closing of the contribution and
exchange of the Partnership Interests pursuant to Articles 1 and 2 of the Contribution Agreement: 
 Section 5.1 Waiver of
Rights Under Partnership Agreements; Consents With Respect to Partnership Interests. 
 (a) As of the Closing, each Nominee
waives and relinquishes all rights and benefits (if any) otherwise afforded to such Nominee under any Partnership Agreement including, without limitation, any rights of appraisal, rights of first offer or first refusal, buy/sell agreements, and any
right to consent to or approve of the sale or contribution by the other partners or members of each Partnership of their Partnership Interests to the Operating Partnership, the Company or any direct or indirect subsidiary thereof and any and all
notice provisions related thereto, except for any rights and benefits retained by the Nominee in connection with the Excluded Assets. Each Nominee acknowledges that the agreements contained herein and the transactions contemplated hereby and any
actions taken in contemplation of the transactions contemplated hereby may conflict with, and may not have been contemplated by, certain Partnership Agreements or other agreements among one or more holders of such Partnership Interests or one or
more of the partners of any such Partnership. With respect to each Partnership and each Property, the applicable Nominee expressly gives all Consents (and any consents necessary to authorize the proper parties in interest to give all Consents) and
Waivers it is entitled to give (if any) that are necessary or desirable to (i) facilitate any Conveyance Action (as hereinafter defined) relating to such Partnership or Property, (ii) cause the Partnership to have authority to transfer the
Partnership Interests or Properties to the Operating Partnership, and (iii) receive OP Units and/or Series A Preferred OP Units directly from the Partnership if the Partnership or one or more of the Partnership’s subsidiaries transfers
assets or interests directly to the Operating Partnership and to reduce the consideration otherwise payable by the Operating Partnership hereunder as a result of such direct transfer by the Partnership or its subsidiaries on account of the Nominee
receiving any amount reduced hereunder from such Partnership or its subsidiaries making such direct transfer. In addition, if the transactions contemplated hereby occur, this Agreement shall be deemed to be an amendment to any Partnership Agreement
to the extent the terms herein conflict with the terms thereof, including without limitation, terms with respect to allocations, distributions and the like. In the event the transactions contemplated by this Agreement do not occur, nothing in this
Agreement shall be deemed to be or construed as an amendment or modification of, or commitment of any kind to amend or modify, the Partnership Agreements, which shall remain in full force and effect without modification. 

 

 11 

 (b) As used herein, the term “Conveyance Action” means, with respect to any
Partnership having a direct or indirect ownership interest in any Property Interests, (i) the transfer, conveyance or agreement to convey by a partner thereof or by any holder of an indirect interest therein (whether or not such partner or
holder is the Contributor or a Nominee) directly, by Direct Contribution, Merger, Division or otherwise of its direct or indirect interest in such Partnership or Property to the Operating Partnership or the Company at Closing, if elected by the
Operating Partnership, provided, however, that a Direct Contribution, Subsidiary Contribution, Merger or Division shall not materially and adversely affect the Contributor or any Nominee in any way, including, without limitation, by impacting the
tax treatment to the Contributor or any Nominee, without the prior written consent of the Contributor or such Nominee, or (ii) the entering into by any such partner or holder any agreement relating to (x) the formation of the Operating
Partnership or the Company, or (y) the direct or indirect acquisition by the Operating Partnership or the Company of any such direct or indirect interest or (iii) the taking by any such partner or holder of any action necessary or
desirable to facilitate any of the foregoing, including, without limitation, the following (provided that the same are taken in furtherance of the foregoing): any sale or distribution to any Person of a direct or indirect interest in such
Partnership or Property, the entering into any agreement with any Person that grants to such Person the right to purchase a direct or indirect interest in such Partnership or Property, and the giving of the Consents and Waivers contained in this
Section or consents or waivers similar thereto in form or purpose. 
 (c) As used herein, the term “Consents”
means, with respect to any such Partnership or Property, any consent necessary or desirable under any Partnership Agreement or any other agreement among all or any of the holders of interests therein or any other agreement relating thereto or
referred to therein (i) to cause the Partnership to have authority to permit any and all Conveyance Actions relating to such Partnership or Property or to amend any such Partnership Agreement and/or other agreements so that no provision thereof
prohibits, restricts, impairs or interferes with any Conveyance Action (such amendments to include, without limitation, the deletion of provisions which cause a default under such agreement if interests therein are transferred for cash),
(ii) to admit the Operating Partnership as a substitute member or partner of such Partnership upon the Operating Partnership’s acquisition of the Partnership Interests therein, respectively, and to adopt such amendment as is necessary or
desirable to effect such admission, (iii) to adopt any amendment to the applicable Partnership Agreement as may be reasonably be deemed desirable by the Operating Partnership, either simultaneously with or immediately prior to the acquisition
of any interest therein, and (iv) to continue such Partnership following the transfer of interest therein to the Operating Partnership. 

(d) As used herein, the term “Waivers” means, with respect to a Partnership or a Property, the waiving of any and all
rights (if any) that a Nominee may have with respect to, and (to the extent controlled by such Nominee) that any such other Person may have with respect to, or that may accrue to a Nominee or such other controlled Person upon the occurrence of, a
Conveyance Action relating to such Partnership or Property, including, but not limited to, the following rights: rights of notice, rights to response periods, rights to purchase the direct or indirect interests of another partner in such Partnership
or Property or to sell such Nominee’s or other Person’s direct or indirect interest therein to another partner, rights to sell such Nominee’s or other Person’s direct or indirect interest therein at a price other than as provided
herein, or rights to prohibit, limit, invalidate, otherwise restrict or impair any such Conveyance Action or to cause a termination or dissolution of such Partnership because of such Conveyance Action. Each Nominee further covenants that it will
take no action to enjoin, or seek damages resulting from, any Conveyance Action by any holder of a direct or indirect interest in a Partnership or a Property in which the Partnership Interests represent a direct or indirect interest. 

 

 12 

 The Waivers and Consents contained in this Section shall terminate upon the termination of
this Agreement, except as to transactions completed hereunder prior to termination. 
 ARTICLE VI. 

MISCELLANEOUS 

Section 6.1 Further Assurances. The Nominees and the Operating Partnership and the Company shall take such other actions and
execute such additional documents following the Closing as the other may reasonably request in order to effect the transactions contemplated hereby. 

Section 6.2 Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument. 
 Section 6.3 Governing Law. This Agreement
shall be governed by the internal laws of the State of California, without regard to the choice of laws provisions thereof. 

Section 6.4 Amendment; Waiver. Any amendment hereto shall be in writing and signed by all parties hereto. No waiver of any
provisions of this Agreement shall be valid unless in writing and signed by the party against whom enforcement is sought. 

Section 6.5 Entire Agreement. This Agreement, the exhibits and schedules hereto and the agreements referred to in Sections 4.1 and
4.2 hereof constitute the entire agreement and supersede conflicting provisions set forth in all other prior agreements and understandings, both written and oral, among the parties with respect to the subject matter hereof and thereof, as the case
may be. 
 Section 6.6 Assignability. This Agreement shall be binding upon, and shall be enforceable by and inure to the
benefit of, the parties hereto and their respective heirs, legal representatives, successors and assigns; provided, however, that this Agreement may not be assigned (except by operation of law) by any party without the prior written consent of the
other parties, and any attempted assignment without such consent shall be void and of no effect, except that the Operating Partnership may assign its rights and obligations hereunder to an affiliate. 

Section 6.7 Titles. The titles and captions of the Articles, Sections and paragraphs of this Agreement are included for
convenience of reference only and shall have no effect on the construction or meaning of this Agreement. 
 Section 6.8 Third
Party Beneficiary. Except as may be expressly provided or incorporated by reference herein, including, without limitation, the indemnification provisions hereof, no provision of this Agreement is intended, nor shall it be interpreted, to provide
or create any third party beneficiary rights or any other rights of any kind in any customer, affiliate, stockholder, partner, member, director, officer or employee of any party hereto or any other person or entity. 

Section 6.9 Severability. If any provision of this Agreement, or the application thereof, is for any reason held to any extent to
be invalid or unenforceable, the remainder of this Agreement and application of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of the parties hereto. The parties further agree to replace
such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of the void or unenforceable provision and to execute any amendment,
consent or agreement deemed necessary or desirable by the Operating Partnership to effect such replacement. 
  

 13 

 Section 6.10 Reliance. Each party to this Agreement acknowledges and agrees that it
is not relying on tax advice or other advice from the other party to this Agreement, and that it has or will consult with its own advisors. Except to the extent attributable to a breach by the Operating Partnership of any tax-related
representations, warranties or covenants set forth in this Agreement or any Exhibit to this Agreement or the Contribution Agreement (including the Tax Protection Agreements), the Operating Partnership shall not be liable for any damages resulting
from a successful challenge of the treatment or characterization by any taxing authority of the transactions contemplated herein. 

Section 6.11 Survival. It is the express intention and agreement of the parties hereto that the representations, warranties and
covenants of each of the Nominees set forth in this Agreement shall survive the consummation of the transactions contemplated hereby, subject, however, to the limitations set forth in Section 3.7. The provisions of this Agreement that
contemplate performance after the Closing and the obligations of the parties not fully performed at the Closing shall survive the Closing and shall not be deemed to be merged into or waived by the instruments of Closing. Notwithstanding any
provision to the contrary set forth herein, in the event that the Closing shall not occur, the Nominees shall have no liability hereunder or under any document or other items delivered pursuant hereto. 

Section 6.12 Notice. Any notice to be given hereunder by any party to the other shall be given in writing by either
(i) personal delivery, (ii) registered or certified mail, postage prepaid, return receipt requested, or (iii) facsimile transmission (provided such facsimile is followed by an original of such notice by mail or personal delivery as
provided herein), and any such notice shall be deemed communicated as of the date of delivery (including delivery by overnight courier, certified mail or facsimile). Mailed notices shall be addressed as set forth below, but any party may change the
address set forth below by written notice to other parties in accordance with this paragraph. 
 To the Company and/or the
Operating Partnership: 
 11601 Wilshire Boulevard, Suite 1600 

Los Angeles, California 90025 

Phone: (310) 445-5702 

Facsimile: (310) 445-5710 

Attn: Mark Lammas 

With a copy (which shall not constitute notice) to: 

Latham & Watkins, LLP 

355 South Grand Avenue 

Los Angeles, CA 90071-1560 

Phone: (213) 891-8640 

Facsimile: (213) 891-8763 

Attn: Brad Helms 
  

 14 

 To the Nominees: 

As set forth on the Signature Page 

With a copy (which shall not constitute notice) to: 

Glenborough Fund XIV, L.P. 

400 South El Camino Real, 11th Floor 

San Mateo, California 94402-1708 

Phone: 650-343-9300 

Attn: General Counsel 

And a copy (which shall not constitute notice) to: 

Goodwin Procter LLP 

53 State Street 

Boston, Massachusetts 02109-2802 

Fax: 617-523-1231 

Attn: Mark Opper, Esq. 

Section 6.13 Equitable Remedies. The parties agree that irreparable damage would occur in the event that any of the provisions of
this Agreement were not performed in accordance with the specific terms hereof or were otherwise breached. It is accordingly agreed that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to
enforce specifically the terms and provisions hereof in any federal or state court located in California (as to which the parties agree to submit to jurisdiction for the purpose of such action), this being in addition to any other remedy to which
the parties are entitled under this Agreement; provided, however, that nothing in this Agreement shall be construed to permit the Nominees to enforce consummation of the Public Offering. 

Section 6.14 Dispute Resolution. The parties hereby agree that, in order to obtain prompt and expeditious resolution of any
disputes under this Agreement, each claim, dispute or controversy of whatever nature, arising out of, in connection with, or in relation to the interpretation, performance or breach of this Agreement (or any other agreement contemplated by or
related to this Agreement or any other agreement between the parties), including without limitation any claim based on contract, tort or statute, or the arbitrability of any claim hereunder (an “Arbitrable Claim”), shall, subject to
Section 6.13 above, be settled by final and binding arbitration conducted in Los Angeles, California. The arbitrability of any Arbitrable Claims under this Agreement shall be resolved in accordance with a two-step dispute resolution process
administered by Judicial Arbitration & Mediation Services, Inc. (“JAMS”) involving, first, mediation before a retired judge from the JAMS panel, followed, if necessary, by final and binding arbitration before the same, or
if requested by either party, another JAMS panelist. Such dispute resolution process shall be confidential and shall be conducted in accordance with California Evidence Code Section 1119. 

 

 15 

 (a) Mediation. In the event any Arbitrable Claim is not resolved by an informal
negotiation between the parties within fifteen (15) days after either party receives written notice that a Arbitrable Claim exists, the matter shall be referred to the Los Angeles, California office of JAMS, or any other office agreed to by the
parties, for an informal, non-binding mediation consisting of one or more conferences between the parties in which a retired judge will seek to guide the parties to a resolution of the Arbitrable Claims. The parties shall select a mutually
acceptable neutral arbitrator from among the JAMS panel of mediators. In the event the parties cannot agree on a mediator, the Administrator of JAMS will appoint a mediator. The mediation process shall continue until the earliest to occur of the
following: (i) the Arbitrable Claims are resolved, (ii) the mediator makes a finding that there is no possibility of resolution through mediation, or (iii) thirty (30) days have elapsed since the Arbitrable Claim was first
scheduled for mediation. 
 (b) Arbitration. Should any Arbitrable Claims remain after the completion of the mediation
process described above, the parties agree to submit all remaining Arbitrable Claims to final and binding arbitration administered by JAMS in accordance with the then existing JAMS Arbitration Rules. Neither party nor the arbitrator shall disclose
the existence, content, or results of any arbitration hereunder without the prior written consent of all parties. Except as provided herein, the California Arbitration Act shall govern the interpretation, enforcement and all proceedings pursuant to
this subparagraph. The arbitrator is without jurisdiction to apply any substantive law other than the laws selected or otherwise expressly provided in this Agreement. The arbitrator shall render an award and a written, reasoned opinion in support
thereof. Judgment upon the award may be entered in any court having jurisdiction thereof. 
 (c) Survivability. This
dispute resolution process shall survive the termination of this Agreement. The parties expressly acknowledge that by signing this Agreement, they are giving up their respective right to a jury trial. 

Section 6.15 Enforcement Costs. Should either party institute any action or proceeding under Section 6.14 above (or, with
respect to the Operating Partnership, Sections 6.13 or 6.14 above), the prevailing party shall be entitled to receive all reasonable costs and expenses (including reasonable attorneys’ fees) incurred by such prevailing party in connection with
such action or proceeding. A party entitled to recover costs and expenses under this Section shall also be entitled to recover all costs and expenses (including reasonable attorneys’ fees) incurred in the enforcement of any judgment or
settlement obtained in such action or proceeding and provision (and in any such judgment provision shall be made for the recovery of such post-judgment costs and expenses). 

Section 6.16 Several Liability. It is understood and acknowledged that to the extent any Nominee makes a representation, warranty
or covenant hereunder, or assumes liability for indemnification or otherwise hereunder, the same is made or assumed by such Nominee severally, and not jointly or jointly and severally with any other Nominee. 

Section 6.17 Term of Agreement. This Agreement shall automatically terminate upon the termination of the Contribution Agreement
and shall thereafter be of no further force and effect, and thereafter neither the Operating Partnership nor the Nominees shall have any further obligations hereunder except as specifically set forth herein. 

[signature page to follow] 
  

 16 

 IN WITNESS WHEREOF, the parties have executed this Representation, Warranty and Indemnity
Agreement as of the date first written above. 
  

					
	“OPERATING PARTNERSHIP”
	
	Hudson Pacific Properties, L.P.,
	a Maryland limited partnership
		
	By:	 	Hudson Pacific Properties, Inc.
	a Maryland corporation
	Its:	 	General Partner
			
		 	By:	 	  

		 		 	Name:
		 		 	Title: Chief Executive Officer
	
	“COMPANY”
	
	Hudson Pacific Properties, Inc.
			
	By:	 		 	  

		 		 	Name:
		 		 	Title:

 [signatures continue on
following page] 
  

 17 

			
	“NOMINEES”
	
	  

		
	By:	 	  

		 	Name:
		 	Title:
		
	Address:	 	  

	  

	  

	
	  

		
	By:	 	  

		 	Name:
		 	Title:
		
	Address:	 	  

	  

	  

	
	  

		
	By:	 	  

		 	Name:
		 	Title:
		
	Address:	 	  

	  

	  

	
	  

		
	By:	 	  

		 	Name:
		 	Title:
		
	Address:	 	  

	  

	  

 

 18 

 EXHIBIT A 

NOMINEES 
 NFG
LIMITED PARTNERSHIP 
 KEELY SELLERS 

ROSS HOLDING & MANAGEMENT COMPANY 

RAYMOND G. AZAR AND ELEANOR K. AZAR 

ROBERT BATINOVICH, TRUSTEE, ROBERT BATINOVICH TRUST 

JEANNINE F. CELLA 

JERI E. EATON 

TERRY L. EATON 

JULIE L. GURNIK 

ROBIN S. LAUTH 

LAWRENCE B. PALMER 

RUSSELL D. RICHARDSON 
  

 EXHIBIT A 

 EXHIBIT B 

FORM OF CONTRIBUTION AGREEMENT 
  

 EXHIBIT BSubscription Agreement

 Exhibit 10.18 

 
  

 
 SUBSCRIPTION AGREEMENT 

 by and among 

FARALLON CAPITAL PARTNERS, L.P. 

FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P. 

FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P. 

VICTOR J. COLEMAN 

and 

Hudson Pacific Properties, Inc. 

Dated as of February 15, 2010 
  

 
  

 SUBSCRIPTION AGREEMENT 

THIS SUBSCRIPTION AGREEMENT (this “Agreement”) is made and entered into as of February 15, 2010 by and among Hudson Pacific
Properties, Inc., a Maryland corporation (the “Company”), Farallon Capital Partners, L.P., a California limited partnership (“FCP”), Farallon Capital Institutional Partners, L.P., a California limited partnership
(“FCIP”), Farallon Capital Institutional Partners III, L.P., a Delaware limited partnership (“FCIPIII”), and Victor J. Coleman (“Coleman”). Each of FCP, FCIP, FCIPIII and Coleman may be referred to
herein as an “Investor” and, collectively, as the “Investors.” 
 RECITALS 

A. The Company proposes to undertake an underwritten initial public offering (the “IPO”) of its common stock, par value $0.01 per share
(the “Common Stock”). 
 B. The Investors desire to purchase Common Stock of the Company in a private placement transaction
exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(2) of the Securities Act and Rule 506 of Regulation D (“Regulation D”)
promulgated thereunder by the Securities and Exchange Commission. 
 NOW, THEREFORE, for and in consideration of the foregoing premises, and the
mutual undertakings set forth below, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

TERMS OF AGREEMENT 

ARTICLE I. 

IRREVOCABLE SUBSCRIPTION FOR SHARES. 

Section 1.1 Each Investor irrevocably subscribes for and agrees to purchase the number of shares of Common Stock indicated in this
Subscription Agreement on the terms provided for herein. The Investor agrees to and understands the terms and conditions upon which the Common Stock is being offered. The price per share paid by the Investor shall be the initial public offering
price for the Common Stock in the IPO. The aggregate purchase price for the shares of Common Stock purchased by each Investor will be the dollar amount set forth opposite the name of such Investor on Schedule A to this Agreement (the
“Committed Purchase Amount”), and the number of shares of Common Stock purchased by each Investor will be the number obtained by dividing the Committed Purchase Amount for such Investor by the initial public offering price per share
for the Common Stock in the IPO. The date, time and place of the consummation of the IPO shall be referred to herein as the “IPO Closing.” 
  

 1 

 ARTICLE II.  

CONDITIONS; CLOSING 

Section 2.1 Conditions to the Company’s Obligations. The obligations of the Company to effect the transactions
contemplated hereby shall be subject to the following conditions precedent: 
 (i) The representations and warranties of each
Investor contained in this Agreement shall have been true and correct in all material respects on the date such representations and warranties were made, and on and as of the Closing Date as if made on and as of such date; 

(ii) The obligations of each Investor contained in this Agreement shall have been duly performed on or before the Closing Date and no
such Investor shall have breached any of its covenants contained herein in any material respect; 
 (iii) Concurrently with the
Closing, each Investor shall have executed and delivered to the Company the documents required to be delivered by such Investor pursuant to Section 2.4 hereof; and 

(iv) No order, statute, rule, regulation, executive order, injunction, stay, decree or restraining order shall have been enacted,
entered, promulgated or enforced by any court of competent jurisdiction or governmental entity that prohibits the consummation of the transactions contemplated hereby, and no litigation or governmental proceeding seeking such an order shall be
pending or threatened. 
 Any or all of the foregoing conditions may be waived by the Company in its sole and absolute
discretion. 
 Section 2.2 Conditions to the Investors’ Obligations. The obligations of each Investor to effect
the transactions contemplated hereby shall be subject to the following conditions precedent: 
 (i) The representations and
warranties of the Company contained in this Agreement shall have been true and correct in all material respects on the date such representations and warranties were made, and on and as of the Closing Date as if made on and as of such date;

 (ii) The obligations of the Company contained in this Agreement shall have been duly performed on or before the Closing Date
and the Company shall not have breached any of its covenants contained herein in any material respect; 
 (iii) Concurrently
with the Closing, the Company shall each have executed and delivered to the Investors the documents required to be delivered pursuant to Section 2.4 hereof; 

(iv) No order, statute, rule, regulation, executive order, injunction, stay, decree or restraining order shall have been enacted,
entered, promulgated or enforced by any court of competent jurisdiction or governmental entity that prohibits the consummation of the transactions contemplated hereby, and no litigation or governmental proceeding seeking such an order shall be
pending or threatened; and 
  

 2 

 (v) The IPO Closing shall be occurring concurrently with the Closing (or the Closing shall
occur prior to, but be conditioned upon the immediate subsequent occurrence of, the IPO Closing). 
 Section 2.3 Time
and Place. The date, time and place of the consummation of the transactions contemplated hereunder (the “Closing” or “Closing Date”) shall occur concurrently with (or prior to, but conditioned upon the immediate
subsequent occurrence of) the IPO Closing, in the office of Latham & Watkins LLP, 355 South Grand Avenue, Los Angeles, California. 

Section 2.4 Closing Deliveries. At the Closing, each Investor will pay its Committed Purchase Amount in cash by wire transfer
of immediately available funds to an account designated upon reasonable advance notice by the Company. At the Closing, the parties shall make, execute, acknowledge and deliver, or cause to be made, executed, acknowledged and delivered through such
third party as may be applicable, the legal documents and other items (collectively the “Closing Documents”) necessary to carry out the intention of this Agreement and the other transactions contemplated to take place in connection
therewith, which Closing Documents and other items shall include, without limitation, the following: 
 (i) Share Certificates,
evidence of delivery of uncertificated shares of Common Stock by book-entry, and/or other evidence of the transfer of Common Stock to the applicable Investors; 

(ii) The Registration Rights Agreement between the Investors, certain other parties and the Company substantially in the form attached
hereto as Exhibit A; 
 (iii) Lock-up Agreements signed by or on behalf of each Investor, each such Lock-up to be
substantially in the form attached hereto as Exhibit B; 
 If requested by the Company, on the one hand, or any Investor,
on the other hand, each party shall provide to the requesting party a certified copy of all appropriate corporate resolutions or partnership actions authorizing the execution, delivery and performance by such party of this Agreement, any related
documents and the documents listed in this Section 2.4. 
 ARTICLE III. 

REPRESENTATIONS AND WARRANTIES OF THE INVESTORS 

Each Investor, severally, and not jointly or jointly and severally, represents and warrants to the Company as set forth below in this
Article 3, which representations and warranties are true and correct as of the date hereof and will (except to the extent expressly relating to a specified date) be true and correct as of the date of Closing (provided, that Coleman only makes the
below representations and warranties to the extent applicable to an individual and not an entity): 
 Section 3.1
Organization; Authority; Qualification. Such Investor has been duly formed, and is validly existing and in good standing under the laws of the jurisdiction of its formation. Such Investor has all requisite power and authority to enter into
this Agreement, and to carry out the transactions contemplated hereby. 
  

 3 

 Section 3.2 Due Authorization. The execution, delivery and performance of the
Agreement by such Investor have been duly and validly authorized by all necessary action of such Investor and its members or partners. The Agreement constitutes the legal, valid and binding obligation of such Investor, enforceable against such
Investor in accordance with its terms, as such enforceability may be limited by bankruptcy or the application of equitable principles. 

Section 3.3 Consents and Approvals. Except as shall have been satisfied prior to the Closing Date, no consent, waiver,
approval or authorization of any third party or governmental authority or agency is required to be obtained by such Investor in connection with the execution, delivery and performance of the Agreement and the transactions contemplated hereby, except
for those consents, waivers, approvals or authorizations, the failure of which to obtain would not have a material adverse effect on the business, financial condition or results of operations (a “Material Adverse Effect”) of such
Investor. 
 Section 3.4 No Violation. None of the execution, delivery or performance of the Agreement, and the
transactions contemplated hereby does or will, with or without the giving of notice, lapse of time, or both, violate, conflict with, result in a breach of, or constitute a default under or give to others any right of termination, acceleration,
cancellation or other right adverse to the Company of (A) the organizational documents, including the operating agreement, if any, of such Investor, (B) any agreement, document or instrument to which such Investor is a party or by which
such Investor is bound, or (C) any term or provision of any judgment, order, writ, injunction, or decree, or require any approval, consent or waiver of, or make any filing with, any person or governmental or regulatory authority or foreign,
federal, state, local or other law binding on such Investor or by which such Investor or its assets are bound or subject; provided in the case of (B) and (C) above, unless any such violation, conflict, breach, default or right would not
have a Material Adverse Effect. 
 Section 3.5 Investment Purposes. Such Investor acknowledges its understanding
that the offering and issuance of Common Stock to be acquired by it pursuant to this Agreement are intended to be exempt from registration under the Securities Act and that the Company’s reliance on such exemption is predicated in part on the
accuracy and completeness of the representations and warranties of such Investor contained herein. In furtherance thereof, such Investor, severally, and not jointly or jointly and severally, represents and warrants to the Company as follows:

 Section 3.5.1 Investment. Such Investor is acquiring Common Stock hereunder solely for its own account and not
with a view to, or for offer or sale in connection with, any distribution thereof. Such Investor agrees and acknowledges that it will not, directly or indirectly, offer, transfer, sell, assign, pledge, hypothecate or otherwise dispose of
(hereinafter, “Transfer”) any of the Common Stock acquired hereunder, unless (i) the Transfer is pursuant to an effective registration statement under the Securities Act and qualification or other compliance under applicable
blue sky or state securities laws, or (ii) counsel for such Investor (which counsel shall be reasonably acceptable to the Company, it being agreed that Richards Kibbe & Orbe LLP 

 

 4 

 
is acceptable to the Company) shall have furnished the Company with an opinion, reasonably satisfactory in form and substance to the Company, to the effect that no such registration is required
because of the availability of an exemption from registration under the Securities Act. 
 Section 3.5.2 Knowledge.
Such Investor is knowledgeable, sophisticated and experienced in business and financial matters and fully understands the limitations on transfer imposed by the Federal securities laws and as described in the Agreement. Such Investor is able to bear
the economic risk of holding the Common Stock for an indefinite period and is able to afford the complete loss of its investment in the Common Stock; such Investor has received and reviewed all information and documents about or pertaining to the
Company, the business and prospects of the Company and the issuance of the Common Stock, as such Investor deems necessary or desirable, and has been given the opportunity to obtain any additional information or documents and to ask questions and
receive answers about such information and documents, the Company, the business and prospects of the Company and the Common Stock, which such Investor deems necessary or desirable to evaluate the merits and risks related to its investment in the
Common Stock. Such Investor has reviewed with its legal counsel and tax advisors the forms of Articles of Amendment and Restatement and Amended and Restated Bylaws of the Company and the partnership agreement of the Company’s operating
partnership subsidiary. 
 Section 3.5.3 Holding Period. Such Investor acknowledges that it has been advised that
(i) the shares of Common Stock issued pursuant to this Agreement are “restricted securities” (unless registered in accordance with applicable U.S. securities laws) under applicable federal securities laws and may be disposed of only
pursuant to an effective registration statement or an exemption therefrom and such Investor understands that the Company has no obligation to register such Investor’s Common Stock, except to the extent set forth in the Registration Rights
Agreement; accordingly, such Investor may have to bear indefinitely the economic risks of an investment in such Common Stock, (ii) a restrictive legend in the form hereafter set forth shall be placed on the Share Certificates, and (iii) a
notation shall be made in the appropriate records of the Company indicating that the shares of Common Stock issued hereunder are subject to restrictions on transfer. 

Section 3.5.4 Accredited Investor. Such Investor is an “accredited investor” (as such term is defined in Rule 501
(a) of Regulation D under the Securities Act). Such Investor has previously provided the Company with a duly executed Accredited Investor Questionnaire. No event or circumstance has occurred since delivery of such Investor’s Questionnaire
to make the statements contained therein false or misleading. 
 Section 3.5.5 Legend. Each Share Certificate issued
pursuant to this Agreement, unless registered in accordance with applicable U.S. securities laws, shall bear the following legend: 

The securities evidenced hereby have not been registered under the Securities Act of 1933, as amended (the “Act”), or
the securities laws of any state and may not be sold, transferred or otherwise disposed of in the absence of such registration, unless the transferor delivers to the company an opinion of counsel satisfactory to the company, to the effect that the
proposed sale, transfer or other disposition may be effected without registration under the Act and under applicable state securities or “Blue Sky” laws; 
  

 5 

 In addition to the foregoing legend, each Share Certificate shall bear a legend which generally provides the
following: 
 The shares represented by this certificate are subject to restrictions on Beneficial and Constructive Ownership and
Transfer for the purpose, among others, of the Corporation’s maintenance of its status as a Real Estate Investment Trust under the Internal Revenue Code of 1986, as amended (the “Code”). Subject to certain further restrictions
and except as expressly provided in the Corporation’s Charter, (i) no Person may Beneficially or Constructively Own shares of the Corporation’s Common Stock in excess of 9.8% (in value or number of shares) of the outstanding shares of
Common Stock of the Corporation unless such Person is an Excepted Holder (in which case the Excepted Holder Limit shall be applicable); (ii) no Person may Beneficially or Constructively Own shares of Capital Stock of the Corporation in excess
of 9.8% of the value of the total outstanding shares of Capital Stock of the Corporation, unless such Person is an Excepted Holder (in which case the Excepted Holder Limit shall be applicable); (iii) no Person may Beneficially or Constructively
Own Capital Stock that would result in the Corporation being “closely held” under Section 856(h) of the Code or otherwise cause the Corporation to fail to qualify as a REIT; and (iv) no Person may Transfer shares of Capital Stock
if such Transfer would result in the Capital Stock of the Corporation being owned by fewer than 100 Persons. Any Person who Beneficially or Constructively Owns or attempts to Beneficially or Constructively Own shares of Capital Stock which causes or
will cause a Person to Beneficially or Constructively Own shares of Capital Stock in excess or in violation of the above limitations must immediately notify the Corporation. If any of the restrictions on transfer or ownership set forth in
(i) through (iii) above are violated, the shares of Capital Stock represented hereby will be automatically transferred to a Trustee of a Trust for the benefit of one or more Charitable Beneficiaries. In addition, the Corporation may take
other actions, including redeeming shares upon the terms and conditions specified by the Board of Directors in its sole and absolute discretion if the Board of Directors determines that ownership or a Transfer or other event may violate the
restrictions described above. Furthermore, upon the occurrence of certain events, attempted Transfers in violation of the restrictions described above may be void ab initio. All capitalized terms in this legend have the meanings defined in
the Charter of the Corporation, as the same may be amended from time to time, a copy of which, including the restrictions on transfer and ownership, will be furnished to each holder of Capital Stock of the Corporation on request and without charge.
Requests for such a copy may be directed to the Secretary of the Corporation at its Principal Office. 
 Section 3.6 No
Brokers. Neither such Investor nor any of its officers, directors or employees, to the extent applicable, has employed or made any agreement with any broker, finder or similar agent or any person or firm which will result in the obligation of
the Company or any of its affiliates to pay any finder’s fee, brokerage fees or commissions or similar payment in connection with the transactions contemplated by the Agreement. 

Except as set forth in this Article III, no Investor makes any representation or warranty of any kind, express or implied, and the Company acknowledges
that it has not relied upon any other such representation or warranty. 
  

 6 

 ARTICLE IV. 

REPRESENTATIONS AND WARRANTIES OF THE COMPANY 

The Company represents and warrants to the Investors as set forth below in this Article 4, which representations and warranties are true
and correct as of the date hereof and will (except to the extent expressly relating to a specified date) be true and correct as of the date of Closing: 

Section 4.1 Organization; Authority. The Company has been duly formed and is validly existing under the laws of the
jurisdiction of its formation, and has all requisite power and authority to enter into this Agreement and, to the extent required under applicable law, is qualified to do business and is in good standing in each jurisdiction in which the nature of
its business or the character of its property make such qualification necessary. 
 Section 4.2 Due Authorization.
The execution, delivery and performance of this Agreement by the Company have been duly and validly authorized by all necessary action of the Company. This Agreement constitutes the legal, valid and binding obligation of the Company, enforceable
against the Company in accordance with its terms, as such enforceability may be limited by bankruptcy or the application of equitable principles. 

Section 4.3 Consents and Approvals. Assuming the accuracy of the representations and warranties of the Investors made
hereunder and except in connection with the IPO, no consent, waiver, approval or authorization of any third party or governmental authority or agency is required to be obtained by the Company in connection with the execution, delivery and
performance of this Agreement and the transactions contemplated hereby, except any of the foregoing that shall have been satisfied prior to the Closing Date or the IPO Closing, as applicable, and except for those consents, waivers and approvals or
authorizations, the failure of which to obtain would not have a Material Adverse Effect. 
 Section 4.4
Non-Contravention. Assuming the accuracy of the representations and warranties of the Investors made hereunder, none of the execution, delivery or performance of this Agreement by the Company and the consummation of the subscription
transactions contemplated hereby will (A) result in a default (or an event that, with notice or lapse of time or both would become a default) or give to any third party any right of termination, cancellation, amendment or acceleration under, or
result in any loss of any material benefit, pursuant to any material agreement, document or instrument to which the Company or any of its properties or assets may be bound or (B) violate or conflict with any judgment, order, decree, or law
applicable to the Company or any of its properties or assets; provided in the case of (A) and (B), unless any such default, violation or conflict would not have a Material Adverse Effect. 

Section 4.5 REIT Status. At the effective time of the IPO and Closing, the Company shall be organized in a manner so as to
qualify as a self-administered and self-managed real estate investment trust within the meaning of Section 856 of the Internal Revenue Code of 1986, as amended (a “REIT”). As described in the prospectus relating to the IPO, the
Company intends to elect to be taxed and to operate in a manner that will allow it to qualify as a REIT for federal income tax purposes commencing with its taxable year ending December 31, 2010. 

 

 7 

 Section 4.6 Common Stock. The Common Stock issuable at the Closing in accordance
with the terms of this Agreement will be duly authorized, validly issued, fully paid and nonassessable, and not subject to preemptive or similar rights created by statute or any agreement to which the Company is a party or by which it is bound.

 Section 4.7 No Litigation. There is no action, suit or proceeding pending or, to the Company’s knowledge,
threatened against the Company that, if adversely determined, would have a Material Adverse Effect on the ability of the Company to execute or deliver, or perform its obligations under, this Agreement and the documents executed by it pursuant to
this Agreement or to consummate the transactions contemplated hereby or thereby. 
 Section 4.8 No Prior Business.
Since the date of its formation, the Company has not conducted any business, nor has it incurred any liabilities or obligations (direct or indirect, present or contingent), in each case except in connection with the formation transactions and the
IPO and as contemplated under this Agreement. 
 Section 4.9 No Broker. Neither Company nor any of its officers,
directors or employees, to the extent applicable, has employed or made any agreement with any broker, finder or similar agent or any person or firm which will result in the obligation of any Investor or any of its respective affiliates to pay any
finder’s fee, brokerage fees or commissions or similar payment in connection with transactions contemplated by the Agreement. 
 Except as
set forth in this Article 4, the Company does not make any representation or warranty of any kind, express or implied, and each Investor acknowledges that it has not relied upon any other such representation or warranty. 

ARTICLE V.  

MISCELLANEOUS 

Section 5.1 Information. The Company may request from the Investor such additional information as the Company may deem
necessary to evaluate the eligibility of the Investor to acquire the Common Stock, and may request from time to time such information as the Company may deem necessary to determine the eligibility of the Investor to hold the Common Stock or to
enable the Company to determine the Company’s compliance with applicable regulatory requirements or tax status, and the Investor shall provide such information as may reasonably be requested. 

Section 5.2 Further Assurances. The Investors and the Company shall take such other actions and execute such additional
documents following the Closing as the other may reasonably request in order to effect the transactions contemplated hereby. 

Section 5.3 Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same instrument. 
 Section 5.4 Governing Law. This
Agreement shall be governed by the internal laws of the State of California, without regard to the choice of laws provisions thereof. 
  

 8 

 Section 5.5 Amendment; Waiver. Any amendment hereto shall be in writing and
signed by all parties hereto. No waiver of any provisions of this Agreement shall be valid unless in writing and signed by the party against whom enforcement is sought. 

Section 5.6 Entire Agreement. This Agreement and the exhibits and schedules hereto constitute the entire agreement and
supersede conflicting provisions set forth in all other prior agreements and understandings, both written and oral, among the parties with respect to the subject matter hereof. 

Section 5.7 Assignability. This Agreement shall be binding upon, and shall be enforceable by and inure to the benefit of, the
parties hereto and their respective heirs, legal representatives, successors and assigns; provided, however, that this Agreement may not be assigned (except by operation of law) by any party without the prior written consent of the other parties,
except to an affiliate, and no assignment shall relieve a party from its obligations under this Agreement. 
 Section 5.8
Titles. The titles and captions of the Articles, Sections and paragraphs of this Agreement are included for convenience of reference only and shall have no effect on the construction or meaning of this Agreement. 

Section 5.9 Third Party Beneficiary. Except as may be expressly provided or incorporated by reference herein, including,
without limitation, the indemnification provisions hereof, no provision of this Agreement is intended, nor shall it be interpreted, to provide or create any third party beneficiary rights or any other rights of any kind in any customer, affiliate,
stockholder, partner, member, director, officer or employee of any party hereto or any other person or entity. 

Section 5.10 Severability. If any provision of this Agreement, or the application thereof, is for any reason held to any
extent to be invalid or unenforceable, the remainder of this Agreement and application of such provision to other persons or circumstances will be interpreted so as reasonably to effect the intent of the parties hereto. The parties further agree to
replace such void or unenforceable provision of this Agreement with a valid and enforceable provision that will achieve, to the extent possible, the economic, business and other purposes of the void or unenforceable provision and to execute any
amendment, consent or agreement deemed necessary or desirable by the Company to effect such replacement. 
 Section 5.11
Reliance. Each party to this Agreement acknowledges and agrees that it is not relying on tax advice or other advice from the other party to this Agreement, and that it has or will consult with its own advisors. 

Section 5.12 Survival. It is the express intention and agreement of the parties hereto that the representations, warranties
and covenants of each of the Investors and the Company set forth in this Agreement shall survive the consummation of the transactions contemplated hereby. 

Section 5.13 Notice. Any notice to be given hereunder by any party to the other shall be given in writing by either
(i) personal delivery, (ii) registered or certified mail, postage prepaid, return receipt requested, or (iii) facsimile transmission (provided such facsimile is followed by an original of such notice by mail or personal delivery as
provided herein), and any 
  

 9 

 
such notice shall be deemed communicated as of the date of delivery (including delivery by overnight courier, certified mail or facsimile). Mailed notices shall be addressed as set forth below,
but any party may change the address set forth below by written notice to other parties in accordance with this paragraph. 

To the Company: 

Hudson Pacific Properties, Inc. 

11601 Wilshire Blvd., Suite 1600 

Los Angeles, CA 90025 

Phone: (310) 445-5700 

Facsimile: (310) 445-5710 

Attn: General Counsel 

To the Investors: 

Farallon Capital Partners, L.P. 

One Maritime Plaza, Suite 2100 

San Francisco, California 94111 

Phone: (415) 421 2132 

Facsimile: (415) 421-2133 

Attn: Daniel J. Hirsch 

Farallon Capital Institutional Partners, L.P. 

One Maritime Plaza, Suite 2100 

San Francisco, California 94111 

Phone: (415) 421 2132 

Facsimile: (415) 421-2133 

Attn: Daniel J. Hirsch 

Farallon Capital Institutional Partners III, L.P. 

One Maritime Plaza, Suite 2100 

San Francisco, California 94111 

Phone: (415) 421 2132 

Facsimile: (415) 421-2133 

Attn: Daniel J. Hirsch 

Victor J. Coleman 

11601 Wilshire Blvd. Suite 1600 

Los Angeles, CA 90025 

Phone: 310 445-5700 

Facsimile: (310) 445-5710 

Attn: Victor J. Coleman 

Section 5.14 Equitable Remedies. The parties agree that irreparable damage would occur in the event that any of the
provisions of this Agreement were not performed in accordance with the specific terms hereof or were otherwise breached. It is accordingly agreed that the 

 

 10 

 
parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically the terms and provisions hereof in any federal or state court located
in California (as to which the parties agree to submit to jurisdiction for the purpose of such action), this being in addition to any other remedy to which the parties are entitled under this Agreement; provided, however, that nothing in this
Agreement shall be construed to permit the Investors to enforce consummation of the IPO. 
 Section 5.15 Dispute
Resolution. The parties hereby agree that, in order to obtain prompt and expeditious resolution of any disputes under this Agreement, each claim, dispute or controversy of whatever nature, arising out of, in connection with, or in relation to
the interpretation, performance or breach of this Agreement (or any other agreement contemplated by or related to this Agreement or any other agreement between the parties), including without limitation any claim based on contract, tort or statute,
or the arbitrability of any claim hereunder (an “Arbitrable Claim”), shall, subject to Section 5.13 above, be settled by final and binding arbitration conducted in Los Angeles, California. The arbitrability of any Arbitrable
Claims under this Agreement shall be resolved in accordance with a two-step dispute resolution process administered by Judicial Arbitration & Mediation Services, Inc. (“JAMS”) involving, first, mediation before a retired
judge from the JAMS panel, followed, if necessary, by final and binding arbitration before the same, or if requested by either party, another JAMS panelist. Such dispute resolution process shall be confidential and shall be conducted in accordance
with California Evidence Code Section 1119. 
 Section 5.16 Mediation. In the event any Arbitrable Claim is not
resolved by an informal negotiation between the parties within fifteen (15) days after either party receives written notice that a Arbitrable Claim exists, the matter shall be referred to the Los Angeles, California office of JAMS, or any other
office agreed to by the parties, for an informal, non-binding mediation consisting of one or more conferences between the parties in which a retired judge will seek to guide the parties to a resolution of the Arbitrable Claims. The parties shall
select a mutually acceptable neutral arbitrator from among the JAMS panel of mediators. In the event the parties cannot agree on a mediator, the Administrator of JAMS will appoint a mediator. The mediation process shall continue until the earliest
to occur of the following: (i) the Arbitrable Claims are resolved, (ii) the mediator makes a finding that there is no possibility of resolution through mediation, or (iii) thirty (30) days have elapsed since the Arbitrable Claim
was first scheduled for mediation. 
 Section 5.17 Arbitration. Should any Arbitrable Claims remain after the
completion of the mediation process described above, the parties agree to submit all remaining Arbitrable Claims to final and binding arbitration administered by JAMS in accordance with the then existing JAMS Arbitration Rules. Neither party nor the
arbitrator shall disclose the existence, content, or results of any arbitration hereunder without the prior written consent of all parties. Except as provided herein, the California Arbitration Act shall govern the interpretation, enforcement and
all proceedings pursuant to this subparagraph. The arbitrator is without jurisdiction to apply any substantive law other than the laws selected or otherwise expressly provided in this Agreement. The arbitrator shall render an award and a written,
reasoned opinion in support thereof. Judgment upon the award may be entered in any court having jurisdiction thereof. 
  

 11 

 Section 5.18 Survivability. This dispute resolution process shall survive the
termination of this Agreement. The parties expressly acknowledge that by signing this Agreement, they are giving up their respective right to a jury trial. 

Section 5.19 Enforcement Costs. Should any party institute any action or proceeding under Section 5.15 above (or, with
respect to the Company, Sections 5.16 or 5.17 above), the prevailing party shall be entitled to receive all reasonable costs and expenses (including reasonable attorneys’ fees) incurred by such prevailing party in connection with such action or
proceeding. A party entitled to recover costs and expenses under this Section shall also be entitled to recover all costs and expenses (including reasonable attorneys’ fees) incurred in the enforcement of any judgment or settlement obtained in
such action or proceeding and provision (and in any such judgment provision shall be made for the recovery of such post-judgment costs and expenses). 

Section 5.20 Several Liability. It is understood and acknowledged that to the extent any Investor makes a representation,
warranty or covenant hereunder, or assumes liability for indemnification or otherwise hereunder, the same is made or assumed by such Investor severally, and not jointly or jointly and severally with any other Investor. 

[signature page to follow] 
  

 12 

 IN WITNESS WHEREOF, the parties have executed this Subscription Agreement as of the date first written
above. 
  

			
	“COMPANY”
	
	Hudson Pacific Properties, Inc.
		
	By:	 	  

		 	Name:
		 	Title:
	
	“INVESTORS”
	
	FARALLON CAPITAL PARTNERS, L.P.
	
	By: Farallon Partners, L.L.C., its General Partner
		
	By:	 	  

		 	Name:
		 	Managing Member
	
	FARALLON CAPITAL INSTITUTIONAL PARTNERS, L.P.
	
	By: Farallon Partners, L.L.C., its General Partner
		
	By:	 	  

		 	Name:
		 	Managing Member
	
	FARALLON CAPITAL INSTITUTIONAL PARTNERS III, L.P.
	
	By: Farallon Partners, L.L.C., its General Partner
		
	By:	 	  

		 	Name:
		 	Managing Member
	
	VICTOR J. COLEMAN
	
	  

 

 S-1 

 SCHEDULE A 
  

				
	 Investor
	  	Committed Purchase Amount
	 Farallon Capital Partners, L.P.
	  	$	 
	 Farallon Capital Institutional Partners, L.P.
	  		
	 Farallon Capital Institutional Partners III, L.P.
	  		
	 Victor J. Coleman
	  	$	2,000,000
		  	 	 
		  	$	20,000,000
		  	 	 

  

 Schedule A-1 

 EXHIBIT A 

TO 
 SUBSCRIPTION
AGREEMENT 
 FORM OF REGISTRATION RIGHTS AGREEMENT 
  

 Exhibit A-1 

 EXHIBIT B 

TO 
 SUBSCRIPTION
AGREEMENT 
 FORM OF LOCK-UP AGREEMENT 
  

 Exhibit B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00171-of-00352.parquet"}]]